Digital Therapeutics Market By Application (Obesity, Diabetes, Respiratory disease, CNS Disease, Smoking cessation), By End User (Patients, Providers, Payers, Employers), Industry Trends, Estimation & Forecast, 2017-2025

Digital Therapeutics Market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025

Market Overview:

Digital therapeutics is emerging as the new generation of digital healthcare that implements treatment programs to specific infirmity such as diabetes, heart disease, high blood pressure and pulmonary diseases like COPD. The key factors fueling the growth of global digital therapeutics market are increasing use of smartphones and growing number of internet users. This has led to the digitalization of healthcare and effective management of chronic diseases. According to Forbes, Propeller Health, manufactures sensors that can be attached to the inhaler of people suffering from chronic diseases. This sensor observes the usage of inhaler and provides feedback through a mobile app. In addition, digital therapeutics allows remote consultation to patients in a cost effective manner, which is another crucial factor contributing towards the growth of this market. However, lack of awareness regarding digital healthcare programs, and data privacy issues are restricting the growth of digital therapeutic market. Moreover, the resistance to change behavior among the traditional healthcare providers is yet another determinant hampering the growth of digital therapeutics market. The report provides detailed qualitative and quantitative analysis of the digital therapeutics market. Market size and forecast in terms of value has been provided for the period - (2017 - 2025), for the segments namely application, end user and geography in each of the major regions.

Digital Therapeutics Market Segmentation

By Application • Obesity • Diabetes • Respiratory disease • CNS Disease • Smoking cessation • Others By End-user  • Patients • Providers • Payers • Employers • Others By Geography • North America • U.S. • Canada • Mexico • Europe • U.K. • France • Germany • Italy • Spain • Rest of Europe • Asia-Pacific • China • Japan • India • Korea • Rest of APAC • South America • Brazil • Rest of South America • Rest of the World • Middle East • Africa

CHAPTER 1. INTRODUCTION
1.1. RESEARCH METHODOLOGY
1.1.1. ERC desk research
1.1.2. ERC data synthesis
1.1.3. Data validation and market feedback
1.1.4. ERC data sources

CHAPTER 2. DIGITAL THERAPEUTICS MARKET OVERVIEW
2.1. DIGITAL THERAPEUTICS MARKET INTRODUCTION
2.2. GLOBAL DIGITAL THERAPEUTICS MARKET REVENUE AND GROWTH RATE, 2017-2025
2.2.1. Global Digital Therapeutics Market Revenue (Million USD) and Growth Rate (%), (2017-2025)

CHAPTER 3. GLOBAL DIGITAL THERAPEUTICS MARKET BY END USER, 2017-2025
3.1. PATIENTS
3.2. PROVIDERS
3.3. PAYERS 18
3.4. GLOBAL DIGITAL THERAPEUTICS MARKET REVENUE BY END USER, 2017-2025
3.4.1. Global Digital Therapeutics Market Revenue (Million USD) and Share (%) By End user, 2017-2025
3.4.2. Patients Market Revenue and Growth Rate, 2017-2025
3.4.3. Providers Market Revenue and Growth Rate, 2017-2025
3.4.4. Payers Market Revenue and Growth Rate, 2017-2025

Note: Similar information coverage has been provided for other end user segment.

CHAPTER 4. GLOBAL DIGITAL THERAPEUTICS MARKET BY APPLICATION, 2017-2025
4.1. OBESITY 20
4.2. RESPIRATORY DISEASE
4.3. SMOKING CESSATION
4.4. GLOBAL DIGITAL THERAPEUTICS MARKET REVENUE BY APPLICATION, 2017-2025
4.4.1. Global Digital Therapeutics Market Revenue (Million USD) and Share (%) By Application, 2017-2025
4.4.2. Obesity Market Revenue and Growth Rate, 2017-2025
4.4.3. Respiratory disease Market Revenue and Growth Rate, 2017-2025
4.4.4. Smoking cessation Market Revenue and Growth Rate, 2017-2025

Note: Similar information coverage has been provided for other application segment.

CHAPTER 5. GLOBAL DIGITAL THERAPEUTICS MARKET BY REGION, 2017-2025
5.1. NORTH AMERICA
5.1.1. U.S.
5.1.2. Canada
5.1.3. Mexico
5.2. EUROPE
5.2.1. U.K.
5.2.2. France
5.2.3. Germany
5.2.4. Italy
5.2.5. Spain
5.2.6. Rest of Europe
5.3. ASIA PACIFIC
5.3.1. China
5.3.2. Japan
5.3.3. India
5.3.4. Korea
5.3.5. Rest of APAC
5.4. SOUTH AMERICA
5.4.1. Brazil 23
5.4.2. Rest of South America
5.5. REST OF THE WORLD
5.5.1. Middle East
5.5.2. Africa
5.6. GLOBAL DIGITAL THERAPEUTICS MARKET REVENUE BY REGION, 2017-2025
5.6.1. Global Digital Therapeutics Market Revenue (Million USD) and Share (%) By Region, 2017-2025
5.6.2. North America Market Revenue and Growth Rate, 2017-2025
5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
5.6.5. South America Market Revenue and Growth Rate, 2017-2025
5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025

CHAPTER 6. MARKET DETERMINANTS
6.1. MARKET DRIVERS
6.2. MARKET RESTRAINTS
6.3. MARKET OPPORTUNITIES
6.4. MARKET DETERMINANTS RADAR CHART

CHAPTER 7. GLOBAL DIGITAL THERAPEUTICS MARKET COMPETITION BY SERVICE PROVIDERS
7.1. GLOBAL DIGITAL THERAPEUTICS REVENUE AND SHARE BY SERVICE PROVIDERS (2017-2025)
7.1.1. Global Digital Therapeutics Revenue (Million USD) and Share (%) by Service Providers (2017-2025)
7.2. DIGITAL THERAPEUTICS MARKET COMPETITIVE SITUATION AND TRENDS
7.2.1. Digital Therapeutics Market Share (%) of Top 3 Service Providers
7.2.2. Digital Therapeutics Market Share (%) of Top 5 Service Providers

CHAPTER 8. COMPANY PROFILES
8.1. PROPELLER
8.1.1. Business Overview
8.1.2. Company Basic Information
8.1.3. Digital Therapeutics Product Details
8.1.4. Propeller Digital Therapeutics Revenue and Gross Margin
8.2. AKILI
8.2.1. Business Overview
8.2.2. Company Basic Information
8.2.3. Digital Therapeutics Product Details
8.2.4. Akili Digital Therapeutics Revenue and Gross Margin
8.3. BIG HEALTH
8.3.1. Business Overview
8.3.2. Company Basic Information
8.3.3. Digital Therapeutics Product Details
8.3.4. Big Health Digital Therapeutics Revenue and Gross Margin
8.4. OMANDA
8.4.1. Business Overview
8.4.2. Company Basic Information
8.4.3. Digital Therapeutics Product Details
8.4.4. Omanda Digital Therapeutics Revenue and Gross Margin
8.5. PEAR THERAPEUTICS
8.5.1. Business Overview
8.5.2. Company Basic Information
8.5.3. Digital Therapeutics Product Details
8.5.4. Pear Therapeutics Digital Therapeutics Revenue and Gross Margin
8.6. COGNOA
8.6.1. Business Overview
8.6.2. Company Basic Information
8.6.3. Digital Therapeutics Product Details
8.6.4. Cognoa Digital Therapeutics Revenue and Gross Margin
8.7. WELLDOC
8.7.1. Business Overview
8.7.2. Company Basic Information
8.7.3. Digital Therapeutics Product Details
8.7.4. WellDoc Digital Therapeutics Revenue and Gross Margin
8.8. SONOFI
8.8.1. Business Overview
8.8.2. Company Basic Information
8.8.3. Digital Therapeutics Product Details
8.8.4. Sonofi Digital Therapeutics Revenue and Gross Margin
8.9. VOLUNTIS
8.9.1. Business Overview
8.9.2. Company Basic Information
8.9.3. Digital Therapeutics Product Details
8.9.4. Voluntis Digital Therapeutics Revenue and Gross Margin

CHAPTER 9. DIGITAL THERAPEUTICS MARKET VALUE CHAIN ANALYSIS
9.1. DIGITAL THERAPEUTICS INDUSTRIAL CHAIN ANALYSIS
9.2. CONSUMER ANALYSIS
9.2.1. Consumer 1
9.2.2. Consumer 2
9.2.3. Consumer 3
9.2.4. Consumer 4

• Propeller
• Akili
• Big Health
• Omanda
• Pear Therapeutics
• Cognoa
• WellDoc
• Sonofi
• Voluntis

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS